Results 161 to 170 of about 68,762 (185)

Middle-Aged Women - A High-Risk Group for Post-Myocardial Infarction Mortality. [PDF]

Arq Bras Cardiol
Lopes MAAAM, Viana M, Nóbrega J, Medeiros HNAA, Oliveira GMM.   +4 more
europepmc   +1 more source

Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]

J Bras Nefrol
Mathew GG.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Lancet, The, 2021
Birgit Vogel, Monica Acevedo, Yolande Appelman   +2 more
exaly  

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

Lancet, The, 2022
Jan Verbakel, Geert Molenberghs, Geraldine Cambridge   +2 more
exaly  

Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians, 2004
Ted Gansler
exaly  

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

Ca-A Cancer Journal for Clinicians, 2010
Richard V Milani, Anthony DAmico
exaly  

Strategies to increase nitric oxide signalling in cardiovascular disease

Nature Reviews Drug Discovery, 2015
Jon O Lundberg, Mark T Gladwin, eddie weitzberg   +2 more
exaly